GLP-1 Weight-Loss Drugs May Rewire the Body Against Disease, Doctors Say
New evidence and clinician experiences point to broader health benefits of GLP-1 medications beyond weight loss and diabetes.
New evidence and clinician experiences point to broader health benefits of GLP-1 medications beyond weight loss and diabetes.
New research and clinical experience point to broader benefits of GLP-1 receptor agonists, from cardiovascular to inflammatory conditions, with doctors urging careful, guided use.
Novo Nordisk patent expiry opens door for cheaper semaglutide; NHS access, safety and supply concerns persist
Dr. Gladys Sanda outlines a three-step approach that treats ear health, emotional response, and attention to help people live with tinnitus
A journalist's month-long cleanse, conflicting tests and medical cautions illuminate uncertainty around a popular trend.
A travel-safety expert outlines how to handle check-in discreetly and secure a hotel room after arrival.
Dr. Gladys Sanda outlines a three-step program that treats ears, emotions and attention to reduce tinnitus distress.
A pseudonymous 26-year-old reveals why some young adults are using gamma-hydroxybutyrate recreationally and the risks they face.
A first-person account examines why some young workers are turning to gamma-hydroxybutyrate, a dangerous date-rape drug, for recreation and the health and legal risks involved.